Latest Insider Transactions at Immunic, Inc. (IMUX)
This section provides a real-time view of insider transactions for Immunic, Inc. (IMUX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IMMUNIC, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IMMUNIC, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2024
|
Richard Alan Rudick Director |
BUY
Open market or private purchase
|
Direct |
87,300
+50.0%
|
$87,300
$1.15 P/Share
|
|
Feb 26
2024
|
Daniel Vitt CEO and Director |
BUY
Open market or private purchase
|
Indirect |
14,000
+3.46%
|
$14,000
$1.31 P/Share
|
|
May 15
2023
|
Glenn Whaley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+16.39%
|
$5,000
$1.75 P/Share
|
|
Dec 14
2022
|
Joerg Neermann Director |
BUY
Open market or private purchase
|
Direct |
47,000
+31.97%
|
$47,000
$1.26 P/Share
|
|
Dec 13
2022
|
Joerg Neermann Director |
BUY
Open market or private purchase
|
Direct |
35,000
+39.77%
|
$35,000
$1.25 P/Share
|
|
Nov 23
2022
|
Joerg Neermann Director |
BUY
Open market or private purchase
|
Direct |
18,000
+50.0%
|
$18,000
$1.39 P/Share
|
|
Nov 22
2022
|
Daniel Vitt CEO and Director |
BUY
Open market or private purchase
|
Indirect |
8,000
+2.08%
|
$8,000
$1.35 P/Share
|
|
Nov 07
2022
|
Glenn Whaley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+19.6%
|
$5,000
$1.5 P/Share
|
|
Jun 03
2022
|
Glenn Whaley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,500
+21.78%
|
$10,500
$3.04 P/Share
|
|
Jun 03
2022
|
Daniel Vitt CEO and Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+1.34%
|
$15,000
$3.1 P/Share
|
|
May 12
2022
|
Andreas Muehler Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,500
+1.16%
|
$17,500
$5.1 P/Share
|
|
May 12
2022
|
Duane Nash Executive Chairman |
SELL
Bona fide gift
|
Direct |
6,000
-27.23%
|
-
|
|
May 12
2022
|
Duane Nash Executive Chairman |
BUY
Open market or private purchase
|
Direct |
10,000
+31.22%
|
$50,000
$5.03 P/Share
|
|
May 12
2022
|
Glenn Whaley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+24.86%
|
$15,000
$5.08 P/Share
|
|
Aug 10
2021
|
Duane Nash Executive Chairman |
BUY
Open market or private purchase
|
Direct |
1,000
+6.24%
|
$9,000
$9.8 P/Share
|
|
Aug 10
2021
|
Daniel Vitt CEO and Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.27%
|
$9,000
$9.6 P/Share
|
|
Aug 10
2021
|
Glenn Whaley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+30.0%
|
$13,500
$9.85 P/Share
|
|
May 12
2021
|
Duane Nash Executive Chairman |
BUY
Open market or private purchase
|
Direct |
4,000
+22.18%
|
$48,000
$12.75 P/Share
|
|
Mar 02
2021
|
Andreas Muehler Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,006
+3.29%
|
$150,090
$15.54 P/Share
|
|
Mar 02
2021
|
Glenn Whaley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+33.33%
|
$16,000
$16.48 P/Share
|